An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
Clinical trial NCT05214794 · COMPLETED
Trial details
- NCT number
- NCT05214794
- Sponsor
- Maruho Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2024-06-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.